Asthma

ACCP Asthma

ACCP GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/60221

Contents of this Issue

Navigation

Page 4. of 11

Table 2. Assessing Control and Adjusting Therapy – Youth ≥ 12 Years of Age and Adults Classification of Asthma Control Components of Control Symptoms Night-time awakenings Interference with normal activity Short-acting β2 Lung function > FEV1 -agonist use for symptom control (not prevention of EIB) or peak flow Validated questionnaires* ATAQ ACQ ACT Exacerbations > 80% predicted/ personal best 0 ≤ 0.75 ≥ 20 0-1/year > Maintain current treatment > Consider step down if well controlled for at least 3 months 60-80% predicted/ personal best 1-2 ≥ 1.5 16-19 2-3/year > Step up (1 step) > Reevaluate in 2-6 weeks > For side effects, consider alternative treatment options < 60% predicted/ personal best 3-4 N/A ≤ 15 > 3/year > Consider short course of systemic oral corticosteroids > Step up (1-2 steps) > Revaluate in 2 weeks > For side effects, consider alternative treatment options Treatment-related adverse effects Medication side effects can vary in intensity from none to very troublesome and worrisome. The level of intensity does not correlate to specific levels of control but should be considered in the overall assessment of risk. EIB, exercise-induced bronchospasm *Validated Questionnaires: ATAQ = Asthma Therapy Assessment Questionnaire ACQ = Asthma Control Questionnaire ACT = Asthma Control Test Well Controlled ≤ 2 days/week < 2×/month None ≤ 2 days/week Not Well Controlled > 2 days/week 1-3×/month Some limitation > 2 days/week Very Poorly Controlled Throughout the day ≥ 4×/week Extremely limited Several times/day Notes: • The stepwise approach is meant to assist, not replace, the clinical decision-making required to meet individual patient needs. Minimal Important Difference: 1.0 for the ATAQ; 0.5 for the ACQ; not determined for the ACT • Symptom assessment for periods > 2 weeks should reflect global assessment, such as inquiring whether the patient's asthma is better or worse since the last visit. • Before step-up therapy: ▶ Assess adherence to medications, environmental control, and comorbid conditions. ▶ If an alternative treatment option was used in a step, discontinue it and use a preferred treatment for that step. 3 Risk Recommended action for treatment (Table 3) Impairment

Articles in this issue

Archives of this issue

view archives of Asthma - ACCP Asthma